Drugmaker Hikma Pharmaceuticals said on Thursday that it was on track to meet FY expectations, with solid top-line growth and strong demand across its portfolio helping offset margin pressures and a drop in operating profits.
07 August 2025 10:48:55
Source: Sharecast
If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.
IWeb is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.
